Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial

Dec. 16, 2010

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

CCX-721 has antitumor effects in murine model of multiple myeloma

Dec. 15, 2010

Tasocitinib shows promising pharmacokinetics in ocular tissues

Dec. 15, 2010

ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma

Dec. 15, 2010

EyeGene's EGT-022 shows therapeutic potential in retinopathy model

Dec. 14, 2010

Nerviano discloses promising preclinical/clinical data on new oncolytic compounds

Dec. 14, 2010

Kinase inhibitors from Bayer show oncolytic activity alone and in combination

Dec. 14, 2010

Phase I and preclinical data presented on PD-0332991 in multiple myeloma

Dec. 14, 2010

Oncolytic agent S-110 shows promising preclinical results and advances into clinic

Dec. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...